Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
crispr
life sciences
medicine
national blog main
alphabet
biology
boston
broad institute of harvard and mit
brook byers
cancer
charles chu
clinical trials
codiak biosciences
community
consensus
coronavirus
covid-19
crispr cas14
cutaneous t-cell lymphoma
dao
deals
decheng capital
diagnostic
exosome
extreme
google
health
infectious disease
investing
jazz pharmaceuticals
kleiner perkins
mammoth biosciences
mayfield
medical devices
national top stories
new york blog main
nfx
What
biosciences
4
×
based
begin
company
crispr
faster
fund
tiny
access
agreed
approval
approves
available
big
bio
biotech
bio’s
brings
bubbles
called
cancer
cas
cells
cheaper
class
clinical
codiak
community
coronavirus
covid
dao
desci
develop
diagnostics
early
easy
exosome
exosomes
expects
fda
Language
unset
4
×
Current search:
biosciences
×
unset
×
@cointelegraph.com
6 months ago
DeSci-focused DAO community funds cancer research
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@extremetech.com
3 years ago
FDA Approves CRISPR-Based Coronavirus Test
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
